Stephen V Liu, Director of Thoracic Oncology, Chief of the Division of Hematology and Oncology, and Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a post on shared a post on X:
“Dr. Lizza Hendriks discusses options in PDL1 high NSCLC. While there are differences in approved antibodies, more similar than different.
Choices may be guided by cost and non-clinical factors.”
Other articles featuring Stephen V Liu on OncoDaily.
